Therapeutic Advances, Novel Formulations and Patient Adherence for Management of
MYCOBACTERIUM AVIUM COMPLEX (MAC) LUNG DISEASE
Focus on the Safety, Evidence and Rationale for Inhaled Antimicrobial Suspensions — A Year 2019 and Beyond, Best Practice Update for the ID and Pulmonary Specialist LEARN MORE >
ECP in CTCL, GVHD, Solid Organ Transplant Rejection, and Scleroderma Focus on the Evidence and Clinical Applications LEARN MORE >
From Landmark CV Outcome Trials to the Front Lines of ASCVD Risk Reduction Focus on Trial-Based Evidence for PCSK9-Mediated LDL-C Lowering to Optimize Treatment and Prevention of ASCVD LEARN MORE >
CV Risk Reduction and Glycemic Control in TD2 Focus on GLP-1 RAs and Combination Insulin Formulations LEARN MORE >
Optimizing Glycemic Regulation Through Combination Therapy Focus on the Safety, Convenience, Metabolic Effects, HA1c Control, Complementarity, and Efficacy of Combination Basal Insulin-GLP-1 RA Regimens for FPG and PPG Control. LEARN MORE >
Focus on IL-6 Inhibitors for Optimizing Multimodal Management of RA A Real World Approach to Unmet Needs, Patient-Centric Care, Special Populations, and Sequencing Biologic Therapies for Rheumatoid Arthritis LEARN MORE >

Featured Specialties